학술논문

Stopping 5-aminosalicylates in Crohn's disease patients starting biologic therapy does not increase the risk of adverse clinical outcomes: analysis of two nationwide population-based cohorts
Document Type
Journal
Source
JOURNAL OF CROHNS & COLITIS; MAR 2019, 13 pS310-pS311, 2p. Supplement: 1
Subject
Language
English
ISSN
18764479